Endo International plc (ENDP) |
|
3.3 0.03 (0.92%)
|
10-01 08:28 |
|
Open: |
3.25 |
Pre. Close: |
3.27 |
|
High:
|
3.39 |
Low:
|
3.21 |
|
Volume:
|
3,442,982 |
Market Cap:
|
758M |
|
|
|
|
Endo International Plc operates as a pharmaceutical company. The company is headquartered in Dublin, Dublin and currently employs 2,910 full-time employees. The firm operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals and International Pharmaceuticals. The company has a portfolio of branded pharmaceuticals offered by its U.S. Branded Pharmaceuticals segment that includes brand names, such as Lidoderm, OPANA ER, Voltaren Gel, Percocet, Fortesta Gel, Testim, TESTOPEL, Aveed, Supprelin LA and XIAFLEX. Its non-branded U.S. Generic Pharmaceuticals portfolio consists of products, such as tablets, capsules, powders, injectables, liquids, nasal sprays, ophthalmics and patches. The firm's generics portfolio has a range of dosage forms and delivery systems. The International Pharmaceuticals segment includes various specialty pharmaceutical products for the Canadian, Latin American and world markets. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
3.336 - 3.355 |
3.355 - 3.376 |
|
Low:
|
3.099 - 3.119 |
3.119 - 3.141 |
|
Close:
|
3.151 - 3.187 |
3.187 - 3.226 |
|
Technical analysis |
as of: 2020-09-30 4:41:00 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 4.11 One year: 4.80 |
| Support: |
Support1: 3.03  Support2: 2.72 |
| Resistance: |
Resistance1: 3.52 Resistance2: 4.11 |
| Pivot: |
3.06 |
| Moving Average: |
MA(5): 3.15 MA(20): 3.01
MA(100): 3.43 MA(250): 4.14 |
| MACD: |
MACD(12,26): 0.03 Signal(9): |
| Stochastic oscillator: |
%K(14,3): 62.92 %D(3): 60.41 |
| RSI: |
RSI(14): 55.60 |
| 52-week: |
High: 7.10 Low: 2.08 Change(%): -6.9 |
| Average Vol(K): |
3-Month: 458700 10-Days: 495710 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.ENDP has closed below upper band by 31.1%. Bollinger Bands are 3.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Wed, 30 Sep 2020
$0.11 EPS Expected for Endo International PLC (NASDAQ:ENDP) This Quarter - MarketBeat
Tue, 29 Sep 2020
Endo International plc (NASDAQ:ENDP) on the Path to Ruin - The Oracle Dispatch
Mon, 28 Sep 2020
Weak fundamental momentum pushes Endo International plc (ENDP) lower - Marketing Sentinel
Mon, 28 Sep 2020
Endo (ENDP) Surges: Stock Moves 8.4% Higher - Yahoo Finance
Mon, 28 Sep 2020
Is Endo International plc (NASDAQ:ENDP) still hot this week? - Stocks Register
Fri, 25 Sep 2020
Endo International plc (ENDP) Rises 8.44% for September 25 - equities.com
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Underperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Neutral |
Price to Earnings: |
Outperform |
| Return on Equity: |
Neutral |
Debt to Equity: |
Underperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Drug Manufacturers General Specialty & Generic |
| Shares Out. (M) |
230 |
| Shares Float (M) |
211 |
|
% Held by Insiders
|
0.68 |
|
% Held by Institutions
|
89.27 |
|
Shares Short (K)
|
26,600 |
|
Shares Short P. Month (K)
|
28,280 |
Stock Financials |
|
EPS
|
-0.699 |
|
EPS Est This Year
|
3.520 |
|
EPS Est Next Year
|
3.010 |
|
Book Value (p.s.)
|
-3.110 |
|
Profit Margin
|
-5.25 |
|
Operating Margin
|
23.28 |
|
Return on Assets (ttm)
|
4.5 |
|
Return on Equity (ttm)
|
|
|
Qtrly Rev. Growth
|
-1.7 |
|
Gross Profit (p.s.)
|
5.874 |
|
Sales Per Share
|
13.054 |
|
EBITDA (p.s.)
|
2.165 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
378 |
|
Levered Free Cash Flow (M)
|
418 |
Stock Valuations |
|
PE Ratio
|
-4.57 |
|
PEG Ratio
|
|
|
Price to Book value
|
-1.03 |
|
Price to Sales
|
0.24 |
|
Price to Cash Flow
|
1.94 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
